ROL vs TIL · P/E 41, rev $3.39B vs $51.3M cap
Rollins Inc (ROL) versus Instil Bio Inc. (TIL) — a side-by-side from cached financials, not a winner call.
Rollins Inc (ROL) is a personal services company listed on NYSE.
Instil Bio Inc. (TIL) is a biotechnology company listed on NASDAQ.
Latest reported ROL revenue for 2024-12-31 was $3.39B. Net income was $466.4M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. ROL currently screens at market cap $21.73B and trailing P/E 41.4.
TIL does not have a complete income-statement cache yet.
ROL currently screens at market cap $21.73B and trailing P/E 41.4. TIL currently screens at market cap $51.3M.
Not investment advice. Open the ROL and TIL stock pages for the full models.
Not investment advice.